|
Correction
to
Aledort et al.,
|
| |||||||||||||||||||||||||||||
In our Table 1, the categories of patients with clotting disorders should have been labeled "treated" (meaning that the patients had received some form of clotting-factor concentrate or blood component) and "untreated" (meaning that the patients had not been given any concentrate or component since 1979). Similarly, the categories of patients with congenital anemias should have been labeled "treated," to indicate those who had received blood components for their disorder, and "untreated," to indicate those who had not.
As edited, the table published with our letter may be mistakenly interpreted to mean that the 83 untreated patients with clotting disorders were given clotting-factor concentrate that had undergone no viral inactivation, whereas the 402 treated patients received concentrates that were virally inactivated. None of the patients with congenital anemias were treated with clotting-factor concentrates (as the published version seems to imply). In fact, 242 patients were given blood components, and 80 received no transfusions.
The correctly labeled table is shown here (Table 1).
|
James W. Mosley, M.D.
University of Southern California School of Medicine
Los Angeles, CA 90032
for the Transfusion Safety Study Group
References
| |||||||||||||||||||||||||||||
Related Letters:
Low CD4+ Counts in a Study of Transfusion Safety
Aledort L. M., Operskalski E. A., Dietrich S. L., Koerper M. A., Gjerset G. F., Lusher J. M., Lian E. C.Y., Mosley J. W.
Extract |
Full Text
N Engl J Med 1993;
328:441-442, Feb 11, 1993.
Correspondence
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |
Previous
